A home-based self-directed EEG neurofeedback intervention for people with chronic neuropathic pain following spinal cord injury (the StoPain Trial): description of the intervention

This study describes an EEG neurofeedback intervention for neuropathic pain after spinal cord injury, where participants use a system at home while the control group receives usual care. The intervention aims to regulate abnormal brain activity associated with pain by providing visual or auditory feedback in real-time, helping individuals control their brain rhythms and reduce pain levels. The StoPain trial is the first RCT incorporating an in-house-developed EEG neurofeedback system designed for people with SCI neuropathic pain, aiming to evaluate its efficacy and acceptability.

• 1
  EEG neurofeedback may offer clinically meaningful benefits in pain intensity and pain interference for individuals with chronic pain.
• 2
  The home-based EEG neurofeedback intervention has the potential to increase accessibility, reduce the need for clinical resources, and enhance adherence due to its flexibility.
• 3
  The StoPain trial outcomes aim to provide evidence regarding the intervention’s efficacy and a deeper understanding of its acceptability and usability within the SCI neuropathic pain population.